RAPA-201

DB18446InvestigationalCell transplant therapies

RAPA-201 is an autologous rapamycin-resistant T-cell therapy.

Code names
RAPA-201

Resolves to

Compound
UNIIZ96NAN6CUA

What you can answer from here — as of April 23, 2025

3Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of RAPA-201, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In